Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Anlon Healthcare's Other Operating Expense for the
three
months ended in Mar. 2026 was ₹80 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹175 Mil.
Anlon Healthcare's quarterly Other Operating Expense
declined
from Sep. 2025 (₹60 Mil) to Dec. 2025 (₹35 Mil) but then
increased
from Dec. 2025 (₹35 Mil) to Mar. 2026 (₹80 Mil).
Anlon Healthcare's annual Other Operating Expense
declined
from Mar. 2024 (₹133 Mil) to Mar. 2025 (₹128 Mil) but then
increased
from Mar. 2025 (₹128 Mil) to Mar. 2026 (₹209 Mil).
Anlon Healthcare Other Operating Expense Related Terms
Anlon Healthcare Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Anlon Healthcare's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹175 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of ₹175 Mil mean?
Anlon Healthcare (NSE:AHCL) has a Other Operating Expense of ₹175 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Anlon Healthcare and its competitors.
Is Anlon Healthcare's Other Operating Expense too high?
Anlon Healthcare's current Other Operating Expense is ₹175 Mil. Overall, Anlon Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's Other Operating Expense compare to ZTS and UTHR?
Anlon Healthcare's Other Operating Expense of ₹175 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Anlon Healthcare and its competitors. Anlon Healthcare's current Other Operating Expense is ₹175 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current Other Operating Expense of ₹175 Mil. The current Other Operating Expense is ₹175 Mil. Anlon Healthcare's overall GF Score™ is 17/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current Other Operating Expense is ₹175 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
17GF Score
Get the complete analysis for NSE:AHCL
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AHCL has been successfully added to your 
